Archives: Speakers

Loîc BRIAND is Managing Director for the overall coordination of airport management expertise between Groupe ADP and the international assets of the group. Historical background since more than 15 years was to manage the deployment of expertise on the entire value chain of airport management (including but not limited to airport operations, technical challenges, commercial strategy, governance challenges, especially through the management of technical assistance agreements -TSAs between ADP International (100% subsidiary of Groupe ADP fully dedicated to overseas operations and shareholdings). Since 2021, in addition to the previous mentioned areas, he is leading the Global PMO team for the Smart Airports program which aims to support the digitalisation of the overall operations in the perspective of improving customer satisfaction, enhance and optimise operations. This program involves both the Parisian airports of CDG and ORY, TAV Airports, AIG for Amman International  airport and MZLZ for Zagreb international airport.

Talha, a visionary technology leader with over 14 years of experience, is on a mission to solve customer problems through cutting-edge technology. He has track record of of managing large enterprise product portfolios and launching successful B2B and B2C products in Aviation and Telco domains. He has demonstrated expertise in scaling teams and navigating the challenges of transitioning from a local mindset to a global market where the products he oversees reach over 20+ countries and 40+ enterprise customers worldwide.

In his dynamic career, which spans roles at TAV Technologies, Turkcell, and Huawei Technologies, Talha continues to leave a lasting impact at the crossroads of technology, product management, and leadership. His ability to unite teams around a shared vision is evident in his success in leading and expanding global teams of 30+ members across 10+ countries. His leadership principles are centered on customer-centricity, fostering creativity, and the crucial balance of trusting instincts while rigorously testing against data and feedback. As he navigates the ever-evolving landscape of technology and business, Talha remains dedicated to making a significant and positive influence on the organizations he touches.

Dr. Michael Schlattau joined Zurich-based ECOFIN Software and Technology AG – the
company that develops Finfox – in 2019 and has been Head of Business Consulting since
2021. Prior to that he worked as a research assistant at the Chair of International Management
at the University of the Bundeswehr Munich and as a senior consultant at EY in Munich.
Michael holds a degree in Business Administration from the University of Augsburg (Dipl.-
Kfm.) and earned his doctorate at the University of the Bundeswehr Munich. He was a visiting
scholar at Columbia University in New York and at the Higher School of Economics in
Moscow.

Henk Streefkerk is a physician scientist (MD PhD) with clinical experience in Ear- / Nose- / Throat surgery and a PhD in Neurovascular surgery. Working experience is both in big pharma (>10 years) and bio-tech (>5 years). Henk started his pharma career as a clinical pharmacologist at Organon and Actelion. He then be-came a Translational Medicine Expert at Novartis. After moving into senior safety role, he first led the safety-related aspects of the global marketing authorization application of a heart failure drug (Entresto), followed by the same for a breast cancer drug (Kisqali). At PIQUR, as Chief Medical Officer, he led the global Clinical Development Team to manage 8 global clinical studies in various stages using a Pi3K/mTor inhibitor (bimiralisib).  In view of existing quality and budget constraints, Henk has re-structured the clinical and safety departments of various biotech companies, successfully passing health authority inspections (SwissMedic / ANSM) after setting up the clinical and safety modules of the quality system. He is a co-founder of a MedTech company (Rivia.ch) which develops and commercializes software to support keeping medical oversight of clinical trials. He also setup the quality management system and information security management system according to ISO 9001 and ISO 27001/GDPR. Henk founded his own consultancy company (Streefkerk Life Sciences Consultancy), providing CMO-, Medical Director-, and Drug Safety Officer services to small biotech companies in Europe and in the USA, and is currently working as CEO of Amarna Therapeutics BV, a preclinical gene therapy company in the Netherlands.